TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ZYDURVIS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ZYDURVIS

ST13

US500000097129359

Class

5

Filing

97129359

Registration

6929748

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

10/09/2023

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

11/17/2021

Registration date

12/20/2022

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/20/2022

Last transaction

10/09/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

99

Owner location

Stevenage, GB

Examiner

BUSH, KAREN

Law office

L80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Glaxo Group Limited
Glaxo Group Limited

Representatives

Elizabeth K. Rucki GSK

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Publications

History of USPTO decisions and trademark events.

17 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/09/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/09/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/09/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/09/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/09/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/20/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

12/20/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/09/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/09/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/09/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/04/2022

PUBO

PUBLISHED FOR OPPOSITION

10/04/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/14/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/31/2022

DOCK

ASSIGNED TO EXAMINER

08/29/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/22/2021

NWAP

NEW APPLICATION ENTERED

11/20/2021

Continuous trademark protection

Get notified about every new filing that threatens ZYDURVIS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.